Effects of tranexamic acid and aprotinin on PAF-induced vascular permeability in normal, thrombocytopenic or neutropenic rats.
O'Brien
J G
JG
Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, Canada.
Farmer
P
P
Battistini
B
B
Johnson
R J
RJ
Zaharia
F
F
Sirois
P
P
D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology; D007611:Aprotinin / Q000494:pharmacology*; D001980:Bronchi / Q000098:blood supply; D002199:Capillary Permeability / Q000187:drug effects*; D008297:Male; D009503:Neutropenia / Q000503:physiopathology*; D010972:Platelet Activating Factor / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D013921:Thrombocytopenia / Q000503:physiopathology*; D014132:Trachea / Q000098:blood supply; D014148:Tranexamic Acid / Q000494:pharmacology*; D014361:Trypsin Inhibitors / Q000494:pharmacology
D000933:Antifibrinolytic Agents; D010972:Platelet Activating Factor; D015842:Serine Proteinase Inhibitors; D014361:Trypsin Inhibitors; D014148:Tranexamic Acid; D007611:Aprotinin